Zydus Lifesciences Ordered to Pay Stamp Duty and Penalties Following Asset Acquisition Valuation Dispute
Zydus Lifesciences Limited has received an order from the Office of the Superintendent of Stamps in Gandhinagar concerning the acquisition of assets from Sterling Biotech Limited. The transaction, which involved a Sale Deed executed by Zydus, resulted in the authority determining the market value of the transferred property and concluding that additional stamp duty was payable on the deal.The acquisition involved various assets, including land, buildings, plant, and machinery from Sterling Biotech Limited, described as a joint venture company. The Office of the Superintendent of Stamps determined the market value of these transferred properties to be ₹ 1,542.60 million. Based on this determination, the authority ordered the recovery of alleged deficient stamp duty along with penalties, totaling ₹ 108.54 million.
The details related to the order and the resulting financial demand are presented below:
| Financial Component | Amount (₹) |
|---|---|
| Alleged Deficient Stamp Duty | 53.47 million |
| Penalties Aggregating | 55.07 million |
| Total Demand | 108.54 million |
The authority's order was passed following the determination that the market value of the assets was higher than the value initially adopted for stamp duty purposes. The order directed Zydus to recover the deficient stamp duty and associated penalties, which include specific levies under state regulations.
As per the official response details, the total demand of ₹ 108.54 million consists of:
| Requirement | Amount (₹) |
|---|---|
| Deficient Stamp Duty | 53.47 million |
| Penalty under Rule 9 of Mumbai Stamp (Determination of Market Value) Rules, 1984 | 53.47 million |
| Penalty under Section 39(1)(b) of the Gujarat Stamp Act, 1958 | 1.60 million |
The authority alleged short payment of stamp duty on the transfer document due to discrepancies in the valuation of the transferred assets. Furthermore, it was alleged that certain details pertaining to the construction area and consideration were not fully reflected in the registration documents submitted for the transaction. Zydus Lifesciences Limited stated that it is currently evaluating the order and available legal remedies.
ZYDUSLIFE Stock Price Movement
Shares of Zydus Lifesciences Limited are edging higher to ₹1127.9 as of 12:48 PM today, posting a robust gain of 2.61% in live trading. The stock has traded within the day's range of ₹1097.9 to ₹1128, while seeing 468,059 shares change hands.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.